News Conference News ACC 2019 Myocardial Injury Often Miscoded as Type 2 MI L.A. McKeown April 02, 2019
News Conference News ACC 2019 Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY Yael L. Maxwell March 27, 2019
News Conference News ACC 2019 Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI L.A. McKeown March 27, 2019
News Conference News ACC 2019 Time and Money: PCI Public Reporting Requirements Take Their Toll Michael O'Riordan March 26, 2019
News Conference News ACC 2019 First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results Yael L. Maxwell March 25, 2019
News Conference News ACC 2019 High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI Michael O'Riordan March 21, 2019
News Conference News ACC 2019 No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel Shelley Wood March 19, 2019
News Conference News ACC 2019 COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI L.A. McKeown March 18, 2019
News Conference News ACC 2019 TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients Yael L. Maxwell March 17, 2019
News Conference News ACC 2019 COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions Shelley Wood March 17, 2019
News Conference News ACC 2019 Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN Caitlin E. Cox March 16, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019